What is APTN's health score?

ADAPTIN BIO, INC. (APTN) has a TradeApes health score of 46 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is APTN's estimated fair value?

Based on our 5-year discounted cash flow model, ADAPTIN BIO, INC.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is APTN undervalued or overvalued?

Our model currently rates APTN as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for APTN... Refresh in a moment for the full analysis.

ADAPTIN BIO, INC. (APTN)

Healthcare Inconclusive inconclusive mixed

$6.0

Updated: 2026-06-05

TradeApes Score

Financial Strength

20 Stressed

Operating Trend

60 Healthy

Relative Value

40 Weak

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

+ High ROIC — above 20%, excellent return on invested capital

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.